ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Columbus, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Columbus, OH, USA:

Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

Phase 3

Sumitomo Pharma
Sumitomo Pharma

Gahanna, Ohio, United States and 107 other locations

The objective of this study is to determine the maximum safe dose of Ra-223 in combination with fractionated (split doses) docetaxel when given to su...

Active, not recruiting
Metastatic Castrate Resistant Prostate Cancer
Radiation: Radium 223
Drug: Docetaxel

Phase 1

Tufts University
Tufts University

Columbus, Ohio, United States and 3 other locations

Phase 1b study to assess the combination of ARV-110 and abiraterone in patients with metastatic prostate cancer with rising PSA val...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-110 in Combination with Abiraterone

Phase 1

Arvinas
Arvinas

Columbus, Ohio, United States and 17 other locations

To evaluate the safety and tolerability of Tarlatamab and will determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D).

Active, not recruiting
Neuroendocrine Prostate Cancer
Drug: Tarlatamab

Phase 1

Amgen
Amgen

Columbus, Ohio, United States and 20 other locations

Researchers are looking for a better way to treat men who have biochemically recurrent hormone-naïve prostate cancer.Hormone-naïve ...

Enrolling
Biochemically Recurrent Prostate Cancer
Drug: Enzalutamide
Drug: Darolutamide(BAY1841788, Nubeqa)

Phase 2

Bayer
Bayer

Columbus, Ohio, United States and 4 other locations

clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...

Active, not recruiting
Metastatic Hormone-sensitive Prostate Cancer
Other: ADT
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 2

Bayer
Bayer

Gahanna, Ohio, United States and 29 other locations

Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I\&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate...

Active, not recruiting
Metastasis From Malignant Tumor of Prostate
Drug: Abiraterone with Prednisone or Enzalutamide
Drug: 177Lu-PSMA-I&T

Phase 3

Curium

Gahanna, Ohio, United States and 51 other locations

cemiplimab, or in combination with REGN5678. REGN4336, cemiplimab and REGN5678 are a type of treatment for cancer called immunotherapy,and ...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: Cemiplimab
Drug: Sarilumab

Phase 1, Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Columbus, Ohio, United States and 10 other locations

to radiographic progression-free survival (rPFS) per 1) Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 for soft tissue and/or Prostate...

Active, not recruiting
Hormone-Sensitive Prostate Cancer
Drug: Capivasertib
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Columbus, Ohio, United States and 322 other locations

This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling tim...

Active, not recruiting
Prostate Cancer
Drug: Prednisone
Drug: Apalutamide

Phase 3

Alliance Foundation Trials

Columbus, Ohio, United States and 68 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems